United States Ultrasound Systems Market Outlook to 2022

GlobalData
105 Pages - GLDATA57894
$4,995.00

Summary

GlobalData’s new report, "United States Ultrasound Systems Market Outlook to 2022", provides key market data on the United States Ultrasound Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - 2D Ultrasound Systems, 3D Ultrasound Systems, Real-Time 3D/4D Ultrasound Systems and Hand Held Ultrasound (HHU) Systems.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Ultrasound Systems market segements - 2D Ultrasound Systems, 3D Ultrasound Systems, Real-Time 3D/4D Ultrasound Systems and Hand Held Ultrasound (HHU) Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the United States Ultrasound Systems market.
- Key players covered include Siemens Limited, GE Healthcare Limited, Philips Healthcare and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.

Companies Mentioned

GE Healthcare Ltd
Siemens Limited
Toshiba Medical Systems Corporation
Samsung Medison Co Ltd
Philips Healthcare

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Ultrasound Systems Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Ultrasound Systems Market, United States 9
3.1 Ultrasound Systems Market, United States, Revenue ($m), 2008-2015 9
3.2 Ultrasound Systems Market, United States, Revenue ($m), 2015-2022 11
3.3 Ultrasound Systems Market, United States, Volume (Units), 2008-2015 13
3.4 Ultrasound Systems Market, United States, Volume (Units), 2015-2022 15
3.5 Ultrasound Systems Market, United States, Average Price ($), 2008-2022 17
3.6 Ultrasound Systems Market, United States, Distribution Share by Revenue ($m), 2014-2015 19
3.7 Ultrasound Systems Market, United States, Company Share by Revenue ($m), 2015 20
4 Overview of Key Companies in United States, Ultrasound Systems Market 22
4.1 GE Healthcare Ltd 22
4.1.1 Company Overview 22
4.2 Siemens Limited 22
4.2.1 Company Overview 22
4.3 Toshiba Medical Systems Corporation 22
4.3.1 Company Overview 22
4.4 Samsung Medison Co Ltd 23
4.4.1 Company Overview 23
4.5 Philips Healthcare 23
4.5.1 Company Overview 23
5 Ultrasound Systems Market Pipeline Products 24
6 Financial Deals Landscape 26
6.1 Acquisition 26
6.1.1 BioTelemetry Acquires VirtualScopics for up to USD15.5 Million 26
6.2 Partnerships 28
6.2.1 GE Healthcare Enters into Agreement with Trice Imaging 28
6.2.2 ENDRA Enters into Co-Development Agreement with GE Healthcare 29
6.2.3 SuperSonic Imagine Enters into Distribution Agreement with Sandhill Scientific 30
6.3 Venture Financing 31
6.3.1 Burl Concepts Raises USD3 Million in Venture Financing 31
6.3.2 Sonavex Raises USD2 Million in Venture Financing 32
6.3.3 Rivanna Medical Raises USD0.1 Million in Financing Round 33
6.3.4 Rivanna Medical Raises Additional USD2.8 Million in Financing Round 34
6.3.5 Mirabilis Medica Raises Additional USD2.2 Million in Venture Financing 35
7 Recent Developments 36
7.1 Corporate Communications 36
7.1.1 Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index 36
7.1.2 Dec 19, 2016: Stavros G. Vizirgianakis Appointed President and CEO of Misonix 36
7.1.3 Nov 28, 2016: Misonix Reports Nasdaq's Acceptance of Its Plan to Regain Listing Compliance 37
7.1.4 Nov 22, 2016: USC Roski Eye Institute conducted patient trials for breakthrough refractory glaucoma treatment 37
7.1.5 Nov 22, 2016: Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma Gene Expression Classifier in 2017 38
7.1.6 Oct 24, 2016: Analogic Announces Leadership Transition 39
7.1.7 Sep 22, 2016: Natus Medical Announces Appointment Of Barbara R. Paul, M.d. To Its Board Of Directors 40
7.1.8 Sep 14, 2016: Misonix Appoints Interim CFO 41
7.1.9 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 41
7.1.10 Sep 01, 2016: Verathon Announces the Appointment of Tracy Olson, Vice President of Finance 41
7.1.11 Aug 31, 2016: Bruce Elder Named CEO of MedQuest 42
7.1.12 Aug 29, 2016: Misonix President and Chief Executive Officer to Retire 42
7.1.13 Aug 09, 2016: Konica Minolta Expands Ultrasound Division, Hires Industry Expert Brian T. Noyes 43
7.1.14 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions 44
7.1.15 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market 44
7.1.16 May 10, 2016: Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA 45
7.1.17 May 02, 2016: HeartStitch Launches German Sales of NobleStitch EL 47
7.1.18 Feb 29, 2016: Eisai Anticancer Agent Halaven Newly Approved In Japan For Treatment Of Soft Tissue Sarcoma 48
7.1.19 Feb 04, 2016: Aequus Announces Positive Results from Single-Dose Bioavailability Study of Aripiprazole Transdermal Patch 49
7.1.20 Jan 26, 2016: Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic’s Board 50
7.2 Financial Announcements 51
7.2.1 Dec 06, 2016: Analogic Announces Results for the First Quarter ended October 31, 2016 and Declares Quarterly Cash Dividend 51
7.2.2 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results 52
7.2.3 Oct 25, 2016: Bard Announces Third Quarter Results 54
7.2.4 Oct 19, 2016: Natus Medical Announces Third Quarter 2016 Financial Results 55
7.2.5 Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend 57
7.2.6 Sep 14, 2016: Misonix Files for Extension of Time for Annual Report on Form 10-K 58
7.2.7 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 59
7.2.8 Jul 26, 2016: Bard Announces Second Quarter Results 60
7.2.9 Jul 20, 2016: Natus Medical Announces Record Second Quarter 2016 Financial Results 60
7.2.10 Jul 12, 2016: Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from Phase 2 Clinical Trial of SAGE-547 in Severe Postpartum Depression 62
7.2.11 Jun 10, 2016: Late-Breaking Data Presented at EHA: All Patients with PNH Treated with Once-Monthly Dosing of ALXN1210 in Phase 1/2 Study Exhibit Rapid and Sustained Reductions in LDH 65
7.2.12 Jun 01, 2016: Analogic Announces Results for the Third Quarter Ended April 30, 2016 and Declares Quarterly Cash Dividend 66
7.2.13 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results 67
7.2.14 May 05, 2016: Misonix Announces Third Quarter and Nine-Months 2016 Financial Results 69
7.2.15 Apr 25, 2016: Stemline Therapeutics Announces Oral Presentation of SL-401 Phase 2 BPDCN Data at the 2016 ASCO Annual Meeting 71
7.2.16 Mar 02, 2016: Analogic Announces Results for the Second Quarter Ended January 31, 2016 and Declares Quarterly Cash Dividend 72
7.2.17 Feb 09, 2016: Misonix Announces Second Quarter Fiscal Year 2016 Financial Results 74
7.3 Government and Public Interest 75
7.3.1 Dec 12, 2016: Musculoskeletal Ultrasound Sonography Gains Ground Among Physical Therapists 75
7.3.2 Jun 22, 2016: Novel Antibody against Brain Tumors 76
7.4 Legal And Regulatory 78
7.4.1 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 78
7.5 Other Significant Developments 78
7.5.1 Sep 22, 2016: See. Click. Send. New Cloud-based Ultrasound Solution Enables Instant, Enhanced Collaboration Among Clinicians 78
7.5.2 Aug 31, 2016: Novuson Surgical Awarded $1.47 M Grant by NIH to Mitigate the Effects of Perioperative Bleeding in Surgically Reconstructed Great Vessels in Neonates Utilizing Direct Therapeutic Ultrasound (DTU) 79
7.5.3 Aug 30, 2016: S.C.-Israel R&D Award Announced 79
7.5.4 Aug 15, 2016: Clinical Studies Demonstrate ConforMIS iTotal CR Customized Knee Implants Provide Superior Outcomes and Potential for Economic Savings 80
7.5.5 Aug 09, 2016: Carestream Reduces Energy Consumption, Boosts Recycling Efforts At Oregon and Colorado Manufacturing Facilities 83
7.5.6 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program 83
7.5.7 Jul 06, 2016: SwRI, UTSA invest in two new joint biomaterial research projects 84
7.5.8 Jul 02, 2016: CIVCO Announces New Distributor for Germany and Austria 85
7.5.9 Jun 09, 2016: NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies 85
7.5.10 May 11, 2016: Toshiba’s Portable Ultrasound Provides Life-Changing Imaging During Pediatric Surgical Mission in Tanzania 86
7.5.11 Apr 01, 2016: BTG announces US launch of LC Bead LUMI, ground-breaking radiopaque embolic bead 87
7.5.12 Feb 24, 2016: Galectin Therapeutics Receives U.S. Patent Allowance for GR-MD-02 to Treat Pulmonary Fibrosis 88
7.5.13 Feb 08, 2016: Remedy Pharmaceuticals Announces Acceptance of Two Oral Presentations on Phase 2 Results of CIRARA for CNS-Related Edema at ISC 2016 89
7.5.14 Jan 12, 2016: SIMnext Partners with Limbs & Things to Introduce New DR Doppler Dynamic Ultrasonography Training System 91
7.6 Product News 92
7.6.1 May 13, 2016: RTLS Leader Sonitor Technologies Introduces New Temperature SmartTag 92
7.6.2 May 06, 2016: RTLS Leader Sonitor Technologies Announces Launch of Patient Wandering and Access Monitoring Technology 92
7.6.3 Apr 26, 2016: RTLS (Real Time Location System) Leader Sonitor Technologies Announces Launch of Staff Safety and Duress Technology 93
7.6.4 Feb 27, 2016: Sonitor Technologies To Announce Launch of SenseAlert, SenseSafe and SmartTag Temperature Tags, Enabling Three New Sonitor RTLS Applications At 2016 HIMSS Conference 94
7.6.5 Jan 11, 2016: Teleflex Highlights a Comparison of Eluting vs Non-Eluting Technologies on Peripherally Inserted Central Catheters (PICCs) in Preventing Thrombus Accumulation 95
7.7 Strategy And Business Planning 96
7.7.1 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 96
7.7.2 Aug 11, 2016: Misonix announces exclusive agreement with SonoSpine 96
7.7.3 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR 97
8 Appendix 99
8.1 Research Methodology 100
8.1.1 Coverage 100
8.1.2 Secondary Research 100
8.1.3 Primary Research 101
8.1.4 Market Modeling and Forecasting 102
8.1.5 Company Share Analysis 103
8.1.6 Distribution Share Analysis 104
8.1.7 Benchmarking 104
8.2 GlobalData Consulting 104
8.3 Contact Us 105
8.4 Disclaimer 105

1.1 List of Tables
Table 1: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 10
Table 2: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 12
Table 3: Ultrasound Systems Market, United States, Volume (Units), Historic, 2008-2015 14
Table 4: Ultrasound Systems Market, United States, Volume (Units), Forecast, 2015-2022 16
Table 5: Ultrasound Systems Market, United States, Average Price ($), Historic, 2008-2015 17
Table 6: Ultrasound Systems Market, United States, Average Price ($), Forecast, 2015-2022 18
Table 7: Ultrasound Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 19
Table 8: Ultrasound Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2015 21
Table 9: Ultrasound Systems Market Pipeline Products 24
Table 10: BioTelemetry Acquires VirtualScopics for up to USD15.5 Million 26
Table 11: GE Healthcare Enters into Agreement with Trice Imaging 28
Table 12: ENDRA Enters into Co-Development Agreement with GE Healthcare 29
Table 13: SuperSonic Imagine Enters into Distribution Agreement with Sandhill Scientific 30
Table 14: Burl Concepts Raises USD3 Million in Venture Financing 31
Table 15: Sonavex Raises USD2 Million in Venture Financing 32
Table 16: Rivanna Medical Raises USD0.1 Million in Financing Round 33
Table 17: Rivanna Medical Raises Additional USD2.8 Million in Financing Round 34
Table 18: Mirabilis Medica Raises Additional USD2.2 Million in Venture Financing 35

1.2 List of Figures
Figure 1: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 9
Figure 2: Ultrasound Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 11
Figure 3: Ultrasound Systems Market, United States, Volume (Units), Historic, 2008-2015 13
Figure 4: Ultrasound Systems Market, United States, Volume (Units), Forecast, 2015-2022 15
Figure 5: Ultrasound Systems Market, United States, Company Share (%) 2015 20

$4,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838